Institutional Research in the Past Week: Winner Medical Received the Most Institutional Inquiries

In the past week, more than 230 stocks have been investigated by institutions, with Winner Medical receiving the most attention from research institutions. During the investigation, the company stated that its consumer goods business performed well during this year's "6.18" shopping festival, with significant improvements in key categories and channel development through product innovation, new product iterations, and targeted marketing. Inovance also received research from over a hundred institutions. From a market performance perspective, the average increase of stocks investigated by institutions in the past week was 4.98%. Stocks such as Jingbeifang and Huasheng Lithium Battery rose by more than 30%. During the investigation, Huasheng Lithium Battery stated that the dual trifluoromethyl sulfonimide lithium developed by the company is a new type of lithium salt that can be used as an additive for lithium-ion battery electrolytes and as an electrolyte for solid-state lithium batteries. Currently, the project is still in the small-scale trial production and sample testing stage and does not yet have the capacity for large-scale industrial production. Investors are advised to invest rationally and pay attention to investment risks